IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 118 filers reported holding IMMUNOVANT INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $461,678 | -34.7% | 12,026 | -73.6% | 0.02% | -37.9% |
| Q1 2023 | $707,256 | +586.7% | 45,600 | +143.9% | 0.03% | +625.0% |
| Q1 2022 | $103,000 | -83.4% | 18,700 | -74.3% | 0.00% | -89.7% |
| Q4 2021 | $621,000 | -3.0% | 72,900 | -1.0% | 0.04% | -15.2% |
| Q3 2021 | $640,000 | -56.5% | 73,600 | -47.1% | 0.05% | -67.6% |
| Q2 2021 | $1,470,000 | +307.2% | 139,035 | +516.2% | 0.14% | +317.6% |
| Q1 2021 | $361,000 | -5.7% | 22,564 | +171.9% | 0.03% | -47.7% |
| Q4 2020 | $383,000 | – | 8,300 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |